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Abstract. 
 
Previously the hexapeptide motif 
FXNPXY
 
807
 
 in the cytoplasmic tail of the LDL receptor 
was shown to be essential for clustering in clathrin-
coated pits. We used nuclear magnetic resonance line-
broadening and transferred nuclear Overhauser effect 
measurements to identify the molecule in the clathrin 
lattice that interacts with this hexapeptide, and deter-
mined the structure of the bound motif. The wild-type 
peptide bound in a single conformation with a reverse 
turn at residues NPVY. Tyr
 
807
 
Ser, a peptide that har-
bors a mutation that disrupts receptor clustering, dis-
played markedly reduced interactions. Clustering motif 
peptides interacted with clathrin cages assembled in the 
presence or absence of AP2, with recombinant clathrin 
terminal domains, but not with clathrin hubs. The iden-
tification of terminal domains as the primary site of in-
teraction for FXNPXY
 
807
 
 suggests that adaptor mole-
cules are not required for receptor-mediated 
endocytosis of LDL, and that at least two different ty-
rosine-based internalization motifs exist for clustering 
receptors in coated pits.
Key words: clathrin • endocytosis • LDL receptor • 
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R
 
eceptor
 
-
 
mediated
 
 endocytosis via clathrin-coated
pits is a major mechanism by which cells internal-
ize extracellular ligands and regulate cell surface
receptor traffic. The internalization-defective LDL recep-
tor was the first example of a protein bearing a mutation
that prevents sorting during endocytosis (1). A conserved
hexapeptide sequence in the cytoplasmic tail of the LDL
receptor (FXNPXY where X is any amino acid) has since
been found to be necessary and sufficient for coated pit
clustering (9, 13, 14)
 
.
 
 This sequence has been predicted to
form a reverse turn conformation (12), and the presence of
this conformation in peptides corresponding to the cyto-
plasmic portion of a receptor strongly correlates with the
efficiency of internalization in cultured fibroblasts (2). The
signal for targeting a membrane protein to coated pits,
therefore, depends upon the secondary structure of the
FXNPXY motif.
In contrast to the clear identification of a motif responsi-
ble for LDL receptor clustering, the identity of the mole-
cule(s) within coated pits responsible for capturing the
LDL receptor is not known. Candidate molecules include
the clathrin triskelion and AP2, the two structural compo-
nents of the lattice. Each triskelion is composed of three
heavy (
 
z
 
180 kD) and three light (
 
z
 
33 kD) chain mole-
cules. AP2, by contrast, consists of four subunits: two of
 
z
 
100 kD (adaptins), one of 
 
z
 
50 kD (designated the 
 
m
 
chain), and one of 
 
z
 
20 kD. The carboxy terminus of three
clathrin heavy chains are linked together to form the hub
of the triskelion, while the amino terminus of each has a
flexible globular domain (
 
z
 
55 kD). When the triskelions
are assembled into a lattice, the globular domain pro-
trudes inwardly towards the membrane, and is able to ex-
tend and retract over a range of 15–20 nm
 
 
 
(21). This do-
main as well as the hub is thought to bind APs (23, 24, 34)
that are bound to the membrane by a high-affinity binding
site (30, 58)
 
.
 
 Therefore, the globular domains of each
triskelion in an assembled lattice are in close proximity to
the plane of the membrane.
Originally, receptor clustering in coated pits was thought
to involve a simple interaction between a tyrosine-based
motif in the cytoplasmic portion of the receptor and one or
more components of the clathrin lattice (41). The candi-
date interacting units were an NPXY motif in the recep-
tors (9) and AP2 in the lattice (42). The model became
more complex with the discovery of two additional inter-
nalization motifs: YXX
 
F
 
 (where 
 
F
 
 is large hydrophobic)
and dileucine (reviewed in 50). Additionally, 
 
b
 
-arrestin
acts as an adaptor molecule that targets phosphorylated
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b
 
2
 
-adrenergic receptors to coated pits (18). Clathrin ap-
pears to be the molecule in coated pits that captures arres-
tin, while the 
 
m
 
 chain of AP2 may be responsible for clus-
tering receptors containing YXX
 
F
 
 motifs (4, 38, 39).
Recently, dileucine motifs have been shown to interact
with the 
 
b
 
 subunit of AP-1 (43). Receptors like the EGF
receptor contain both YXX
 
F
 
 and NPXY motifs, though it
is unclear how the motifs function in endocytosis. For in-
stance, the EGF receptor coimmunoprecipitates with AP2
after ligand binding (47), but mutations within the tail of
the EGF receptor that prevent interactions with AP2 do
not affect receptor internalization (35). Moreover, AP2
binding has been mapped to a region that contains a
YXX
 
F
 
 motif, but the EGF receptor does not compete for
internalization with transferrin receptor, which also has a
YXX
 
F
 
 motif (56). Receptors with YXX
 
F
 
 or dileucine
motifs also do not compete with each other for internaliza-
tion (31). The cytoplasmic tails of receptors, therefore,
can contain multiple overlapping signals for targeting to
coated pits and to other membrane domains (7, 32, 45, 50).
Attempts to detect interactions between AP2 and the
FXNPXY motif using plasmon resonance have failed, and
a combinatorial library showed no preference for FXN-
PXY (4). Clustering of the LDL receptor may be due to
weak protein–protein interactions depending on the coop-
erative behavior of multiple proteins in the lattice, or may
require a novel adaptor molecule. The methods used so far
have not identified interactions between the FXNPXY
motif and any of these molecules. Another approach is to
use nuclear magnetic resonance (NMR)
 
1
 
 spectroscopy to
detect interactions between internalization peptides and
clathrin cages. NMR parameters such as line widths (de-
fined as the peak width at half height) and nuclear Over-
hauser effect (NOE) buildup rates change when a rapidly
tumbling peptide binds to a slowly rotating macromole-
cule or molecular complex. These changes identify specific
interactions, and provide three-dimensional information
about the bound conformation of the peptide. A major ad-
vantage of this technique is the ability to test for interac-
tions between the peptide and a macromolecular system
(26). Using this approach, we have identified the globular
domain of the clathrin triskelion as a principle site of inter-
action during LDL receptor clustering in coated pits.
 
Materials and Methods
 
Peptide Synthesis 
 
The peptides FDNPVYQKTT, FDNPVY, FDNPVSQKTT, FDNPVS,
FDNPVA, FDNPVF, and FDNPVL were synthesized using standard
FMOC chemistry with a free COOH terminus and an acylated NH
 
2
 
 termi-
nus. Crude peptides were purified by reverse-phase HPLC on a C18 col-
umn (Vydac, Hesperia, CA), equilibrated in H
 
2
 
O with 0.1% trifluoroace-
tic acid, and eluted with a linear gradient of acetonitrile. The identities of
the peptides were confirmed by mass spectrometry and amino acid analy-
sis. Concentrated stock solutions of peptides were made by dissolving the
peptide in D
 
2
 
O and adjusting the pH to 6.0 with aliquots of concentrated
NaOH.
 
Purification and Assembly of Clathrin/AP Cages 
 
Clathrin coat proteins were isolated from bovine brain by standard proce-
dures (8). The coat proteins were then gel-filtered over a Superdex 200
column (Pharmacia Biotech, Inc., Piscataway, NJ) equilibrated in 0.6 M
Tris at pH 9.0. Clathrin and AP fractions were pooled and loaded directly
onto an anion exchange column (Source Q 15; Pharmacia Biotech, Inc.)
equilibrated in 20 mM ethanolamine, pH 9.0, and eluted with a steep lin-
ear gradient of 1 M NaBr. Clathrin and AP fractions were pooled and con-
centrated using Centriprep 30 (Amicon Corp., Easton, TX). Concentrated
proteins were polymerized (25) by extensive dialysis against NMR sample
buffer (40 mM D
 
4
 
-malonic acid [Cambridge Isotope Labs, Andover, MA],
pH 6.0, 0.2 mM EDTA, 0.2 mM DTT, and 3 mM NaN
 
3
 
). Protein concen-
tration of the polymerized cage complex was determined using the Brad-
ford reagent (Bio-Rad Laboratories, Hercules, CA).
For preparation of cages composed of clathrin or clathrin and AP2, the
purification was slightly modified. An additional anion exchange chroma-
tography step was performed to separate clathrin from AP2 before gel fil-
tration. Each protein was then purified separately as before. AP-2 con-
taining fractions from the second anion exchange step were then pooled
on the basis of Coomassie blue–stained SDS-PAGE. The clathrin fraction
was divided in half, and all of the AP-2 sample was added to one half of
the clathrin. Both samples were concentrated in Centriprep 30 and dia-
lyzed extensively as described above. Equal total protein amounts of
clathrin or clathrin/AP-2 cages were added to each NMR sample, which
contained clathrin (9.7 mg/ml) or clathrin (8.5 mg/ml) and AP-2 (1.2 mg/
ml). Sample purity was confirmed by Coomassie blue–stained SDS-PAGE
gels and by Western blotting with an antibody against 
 
b
 
-adaptin (100/1;
Sigma Chemical Co., St. Louis, MO).
 
Expression and Purification of Recombinant Proteins 
 
The clathrin terminal domain (residues 1–579) was expressed as a glu-
tathione-S-transferase (GST) fusion protein in 
 
Escherichia coli
 
 BL21 cells,
and was prepared as described (17). Glutathione agarose beads (Sigma
Chemical Co.) with the bound GST construct were then washed with
thrombin cleavage buffer (50 mM Tris, 2.5 mM CaCl
 
2
 
, 150 mM NaCl, pH
7.4). The beads were incubated overnight with gentle agitation in the pres-
ence of thrombin (Sigma Chemcial Co.). DTT was added to 10 mM and
allowed to incubate an additional 1 h before eluting the cleaved terminal
domain construct from the beads. Samples were concentrated and dia-
lyzed overnight against NMR sample buffer with 100 mM KCl.
The clathrin hub construct (residues 1074–1483) was expressed as a
hexahistidine construct in 
 
E
 
.
 
 coli
 
 BL21(DE) cells as described (29). Bacte-
rial lysates were incubated with Ni-NTA agarose (QIAGEN Inc., Valen-
cia, CA) overnight and eluted with 250 mM imidazole in 50 mM Tris, pH
7.8. The eluted polypeptides were then loaded directly onto an anion ex-
change column equilibrated in 30 mM Tris, 1 mM EDTA, pH 7.8, and
eluted with a linear gradient of 0.5 M KCl. Fractions were pooled on the
basis of Coomassie blue–stained SDS-PAGE gels. Because the hub
polypeptide aggregated in the NMR sample buffer, both the terminal do-
main and hub polypeptides were dialyzed against 40 mM KPO
 
4
 
,
 
 
 
150 mM
KCl, 0.2 mM EDTA, 3 mM NaN
 
3
 
,
 
 
 
and 0.2 mM DTT pH 7.2.
 
NMR Spectroscopy 
 
All spectra were acquired at 500 MHz and 25
 
8
 
C in sample buffer contain-
ing 10% D
 
2
 
O on a Varian Unity 500 spectrometer with a 5999.7-Hz spec-
tral width using 3-(tetramethylsilyl) propionic acid as a chemical shift ref-
erence. 1D spectra were acquired with 128 transients of 64,000 points zero
filled to 131,072 points (see Fig. 1) or 64 transients of 32,000 points zero
filled to 65,536 points (see Figs. 4 and 5). Line-broadening was measured
as the difference of peak widths at half height using the Felix 2.30 (Biosym
Technologies) program. The broadening is reported as the line-width of
the resonance peak in the presence of cages minus the line-width in the
absence of cages.
 
 
 
Crosspeak intensities were calculated in arbitrary units
of volume using the Felix 2.30 program from spectra acquired at 60-, 100-,
140-, and 220-ms mixing times. The spectra were acquired in phase-sensi-
tive mode (48) with 2 
 
3 
 
256 FIDs of 1024 complex points each. A spectral
width of 5999.7 Hz was used in both dimensions, and 32 transients per FID
were collected. The water signal was suppressed by presaturation.
The relative 
 
K
 
d
 
 for wild-type and position 807 mutant peptides from
clathrin terminal domains was obtained from measurements of the peak
intensities of the Phe (3, 5) aromatic protons for each of the peptides in
the presence and absence of protein. The free and bound populations
were calculated from the following equation:
 
1. 
 
Abbreviations used in this paper
 
: GST, glutathione-S-transferase; m,
medium; NMR, nuclear magnetic resonance; NOE, nuclear Overhauser
effect; PTB, phosphotyrosine binding; s, strong; w, weak. 
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where i is the intensity of the free (i
 
f
 
), the bound (i
 
b
 
), and observed (i
 
o
 
)
resonance, and p
 
f
 
 and p
 
b
 
 are the free and bound populations, respectively.
Since peak intensities are inversely proportional to the transverse relax-
ation rate (1/T
 
2
 
), the population of the free and bound peptide can be esti-
mated from the change in intensity of a given peptide resonance upon ad-
dition of clathrin terminal domain if the T
 
2
 
 of the resonance in the free
and bound forms is known. The T
 
2 
 
for a protein is approximately propor-
tional to the molecular weight, and from the line-widths observed in 20-kD
proteins (3), the expected T
 
2 
 
for a 55-kD protein is 
 
z
 
10 ms. The T
 
2
 
 calcu-
lated from the line-widths of several resonances of the free peptides was
 
z
 
100 ms. The values of i
 
b 
 
were estimated to be i
 
f
 
/10, assuming that the T
 
2
 
s
of the free and bound resonances are 100 and 10 ms, respectively. There-
fore, the calculated populations of p
 
f 
 
and p
 
b
 
 were then used to obtain 
 
K
 
d
 
s
assuming standard protein–ligand equilibrium. Since the 
 
K
 
d
 
s were based
on T
 
2
 
 estimates, their absolute values are likely to be inaccurate. How-
ever, the relative values of the 
 
K
 
d
 
s can be compared because they were all
obtained by the same method.
Distances were calculated only for interresidue NOEs seen in 60 ms
mixing time data sets. Sequential H
 
a
 
 to NH NOEs were not used because
they contained contributions from the free peptide. NOE distance re-
straints were calculated from both wild-type hexa- and decapeptide either
by using bins of weak (w; 1.8–2.3 Å), medium (m; 1.8–3.5 Å), and strong
(s; 1.8–5.0 Å) peaks, or by measured NOE volumes calibrated individually
for each dimension with the average volume of the Phe, Tyr, and Pro
(
 
b
 
/
 
b
 
) NOEs corresponding to 1.75 Å. Structures were calculated by simu-
lated annealing performed with the programs INSIGHTII and NMRCHI-
TECT (Biosym Technologies, San Diego, CA) incorporating either type
of restraint. In short, peptides were heated to 1,000
 
 
 
K, and then the dis-
tance and chiral restraints were slowly increased over 30 ps. The peptides
were then slowly cooled to 300
 
 
 
K while increasing covalent and nonbond
forces over 32 ps. The final structures were then obtained by iteratively
minimizing to a final derivative of 0.01 kcal/mol
 
2
 
1
 
/Å
 
2
 
2
 
 and simulating 30
ps of restrained dynamics. Similar sets of structures were obtained with
both sets of restraints. Stereospecific assignments of Pro(
 
b
 
,d,
 
g
 
) were
based on interresidue distances and geometry. Removal of pseudoatom
restraints for Tyr (
 
d
 
, 
 
e
 
) and Phe(
 
d
 
) was based on the geometry of an initial
set of structures. The final set of 30 restraints was (* denotes pseudoatom
and distance is denoted as s, m, or w): Ac(Me*)::F(H
 
d
 
1
 
), w; F(H
 
d
 
1
 
)::
D(HN), w; F(H
 
b
 
2
 
)::D(HN), w; D(H
 
b
 
2
 
)::N(HN), w; N(H
 
b
 
1
 
)::P(H
 
d
 
S
 
), w;
N(H
 
b
 
2
 
)::P(H
 
d
 
S
 
), m; N(H
 
b
 
1
 
)::P(H
 
d
 
R
 
), w; N(H
 
b
 
2
 
)::P(H
 
d
 
R
 
), w; N(HN)::
P(H
 
d
 
R
 
), w; P(H
 
b
 
R
 
)::V(HN), m; P(H
 
b
 
S
 
)::V(HN), w; P(H
 
d
 
S
 
)::V(HN), w;
V(HN)::Y(HN), s; V(HN)::Y(H
 
d
 
1
 
), w; V(H
 
g
 
1
 
*)::Y(H
 
d
 
1
 
), w; V(H
 
g
 
1
 
*)::
Y(H
 
e
 
1
 
), w; Ac(Me*)::D(HN), w; Ac(Me*)::N(H
 
d
 
21
 
), w; Ac(Me*)::
N(H
 
d
 
22
 
), w; V(HN)::N(H
 
b
 
1
 
), w; V(HN)::N(H
 
b
 
2
 
), w; N(H
 
b
 
1
 
)::Y(H
 
d
 
2
 
), w;
N(H
 
b
 
2
 
)::Y(H
 
d
 
1
 
), w; P(H
 
g
 
s
 
)::Y(H
 
d
 
1
 
), w; P(H
 
g
 
s
 
)::Y(H
 
e1), w; P(Hgs)::
Y(HN), m; P(Hbr)::Y(HN), w; P(Hbr)::Y(Hd1), w; P(Hbr)::Y(He1), w;
P(Ha)::Y(HN), w.
Results
Clathrin triskelions and APs purified from bovine brain
were assembled into membrane-free polyhedral cages us-
ing standard methods (25). We prepared synthetic hexa-
and decapeptides corresponding to the wild-type LDL
receptor internalization motif (FDNPVY and FDNPVY-
QKTT) and to an internalization defective motif (FDN-
PVS and FDNPVSQKTT). Aromatic (Fig. 1, A–F) and
aliphatic (Fig. 1, G and H) side chain regions from one-
dimensional 1H NMR spectra are shown for peptide sam-
ples (2.5 mM) mixed with NMR sample buffer alone, or
buffer containing clathrin cages (20 mg/ml). The wild-type
and mutant peptides exhibited characteristic narrow 1H
line-widths in the absence of cages (Fig. 1, A, D, and G,
and data not shown). Adding cages to wild-type hexa- and
decapeptides caused a pronounced increase in the line
widths, indicative of an interaction between the peptide
and the cages and a consequent slower effective tumbling
time for the peptide (Fig. 1, B, C, and H; 36). By contrast,
1
io
---- p f
i f
---- p b
i b
----- + = the cage-induced line-broadening of mutant peptides was
markedly less than that of wild-type for both the hexa- and
decapeptides, indicating a weaker interaction (Fig. 1, E
and F). As a control for nonspecific binding or viscosity-
induced broadening, we examined the decapeptides in the
presence of 20 mg/ml BSA. Neither peptide displayed ap-
preciable line-broadening (data not shown).
NOE spectroscopy (NOESY) is another method of de-
tecting interactions between peptides and large protein
complexes (26). The hexa- and decapeptides have ineffi-
cient cross-relaxation due to their small size, and thus have
NOE spectra relatively devoid of cross-peaks (data not
shown). A peptide interacting with a large protein com-
plex will develop stronger NOEs because cross-relaxation
is more efficient in the bound state. The resulting spin
populations are then maintained in the free state where
they are observed as an increase in the number and inten-
sity of NOE crosspeaks (10, 11). As shown in Fig. 2 (A and
C), the NOESY spectra of both the deca- and the hexa-
wild-type peptides in the presence of cages contain numer-
ous cross-peaks, many of which are strong. In contrast,
only a few cross-peaks are observed in the NOESY spec-
tra of the mutant peptides in the presence of cages (Fig. 2,
B and D). The large difference in number and intensity of
NOEs at a short mixing time (60 ms) is consistent with the
line-broadening results (Fig. 1), and indicates that the
wild-type peptides have higher affinity for the cages.
Transferred NOEs were not observed with either wild-
type or mutant decapeptide in solutions with 20 mg/ml
BSA, even at long mixing times (300 ms; data not shown).
Figure 1. Differential line-broadening of internalization peptides
in the presence and absence of clathrin-AP cages. Corresponding
regions of 1-dimensional 1H NMR spectra are shown at absolute
intensity for 2.5 mM peptide with or without 20 mg/ml assembled
clathrin/AP cages. (A–F) Aromatic region of the spectrum from
wild-type peptides FDNPVYQKTT alone (A), FDNPVYQKTT
plus cages (B), FDNPVY plus cages (C), and Y807S mutant pep-
tides FDNPVSQKTT alone (D), FDNPVSQKTT plus cages (E),
and FDNPVS plus cages (F). (G and H) Upfield region of wild-
type peptide, FDNPVYQKTT, alone (G) and with cages (H).
The resonances of the aromatic protons are at 7.29, 7.33, and 7.38
ppm for Phe and 6.81 and 7.12 ppm for Tyr and for the methyl
protons at 0.83 and 0.89 ppm for Val(g), 1.25 ppm for Thr9(g),
and 1.18 ppm for Thr10(g).The Journal of Cell Biology, Volume 142, 1998 62
When a peptide binds to a macromolecule, the effective
tumbling rates are slower for protons in the region of the
peptide involved in binding, since protons in other regions
are likely to experience fast internal motions. Thus, cross-
relaxation is more efficient in the regions immobilized by
binding, resulting in faster NOE buildup rates for a given
fixed distance. To analyze the mobility of residues of the
wild-type decapeptide bound to the cages, we first com-
pared the build-up rates of transferred NOEs correspond-
ing to covalently fixed equivalent proton distances. The
similarity in NOE buildup rates (measured with 60-, 100-,
140-, and 220-ms mixing times) for the geminal b protons
from residues F, N, P, and Y indicates that these residues
behave isotropically in the bound state (Fig. 3 A). This
phenomenon was also apparent in the similar line-broad-
ening of the Tyr (eH, 3.45 Hz) and Phe (eH, 3.60 Hz) ring
protons (Fig. 1). By contrast, the buildup rates for Hb/Hg
NOEs decrease towards the COOH terminus of the pep-
tide. Val has the most rapid buildup rate, indicating that it
is immobilized the most, then Thr9, and then Thr10 (Fig. 3
B). This trend was also observed in line-broadening of the
Val (gH1, 5.20 Hz; gH2, 3.82 Hz), Thr9 (gH, 3.18), and
Thr10 (gH, 2.95 Hz) g protons (compare Fig. 1, G and H).
These results indicate that the decapeptide residues out-
side the internalization motif have greater mobility than
those within the motif. Therefore, the same residues
known to be critical for internalization in vivo were immo-
bilized in the presence of cages.
The internalization motif peptide could be interacting
with multiple proteins in the lattice. To distinguish be-
tween the contributions of AP2 and clathrin, we prepared
clathrin cages composed of either clathrin alone or clath-
rin plus purified AP2. AP2 alone could not be tested be-
cause it aggregated under our experimental conditions.
Fig. 4 shows that the wild-type hexapeptide in the pres-
ence of clathrin cages displayed distinct line-broadening
(compare Fig. 4 A with Fig. 4 B). The mutant peptide, by
contrast, showed much less line-broadening (compare Fig.
4 D with Fig. 4 E). Some additional line-broadening was
seen when the wild-type peptide was mixed with cages
composed of both clathrin and AP2 (compare Fig. 4 B
with Fig. 4 C). However, it is likely that the broadening
arose primarily from clathrin (see Discussion). The mutant
peptide (Y807S), by contrast, showed much less line-broad-
ening (compare Fig. 4 B with Fig 4 E, and Fig. 4 C with
Fig. 4 F). These results suggest that the LDL receptor in-
teracts with clathrin through the FXNPXY motif during
receptor clustering in coated pits.
We examined further the interaction between the hexa-
peptides and clathrin using recombinant portions of the
clathrin molecule. The terminal domain of clathrin (resi-
Figure 2. NOESY spectra of wild-type and mutant internaliza-
tion motif peptides in the presence of clathrin-AP cages. Samples
were the same as those in the spectra of Fig. 1. Corresponding ex-
pansions from the aliphatic/amide 1 aromatic region of NOESY
spectra are presented as contour plots at the same level from data
acquired with 60 ms of mixing time. All samples contained 20 mg/ml
cages and 2.5 mM peptide: FDNPVY (A), FDNPVS (B), FDN-
PVYQKTT (C), and FDNPVSQKTT (D).
Figure 3. NOE buildup rates for fixed internuclear distances.
NOE buildup curves from the sample containing the wild-type
decapeptide with cages are shown for the intraresidue Hb/Hb
NOEs of Phe (squares), Asn (diamonds), Pro (circles), and Tyr
(triangles; A), and for the intraresidue Hb/Hg NOEs of Val(Hg1)
(squares), Val(Hg2) (diamonds), Thr9 (circles), and Thr10 (trian-
gles; B). Crosspeak intensities were calculated in arbitrary units
of volume using the program Felix 2.30 from spectra acquired at
60, 100, 140, and 220 ms mixing times.Kibbey et al. Clathrin Clusters LDL Receptors 63
dues 1–579) expressed as a GST fusion protein was puri-
fied, and thrombin was cleaved from GST. Clathrin hubs
(residues 1074–1483) were expressed as a hexaHis-tagged
polypeptide, and were purified by a Ni resin and anion ex-
change. Line-broadening measurements were first made
using the terminal domain at the acidic pH used in the
cage assays. The wild-type peptide (Fig. 5) displayed the
same degree of line-broadening (compare Fig. 5 A with
Fig. 5 B) seen when peptide is incubated in the presence of
clathrin cages. The mutant peptide, by contrast, displayed
much less broadening (compare Fig. 5 C with Fig. 5 D).
Equimolar amounts of either BSA or GST under the same
conditions had no effect (data not shown). We saw a simi-
lar degree of line-broadening at neutral pH (compare Fig.
5 E with Fig. 5 F), but no appreciable broadening was de-
tected when the hub region was substituted for the termi-
nal domain at neutral pH (compare Fig. 5 E with Fig. 5 G).
These results show that the LDL receptor tail selectively
interacts with the terminal domain of clathrin.
The amino acid requirements at position 807 for LDL
receptor internalization (14) have been found to correlate
with the propensity of peptides from that region to form a
reverse turn (2). We examined position 807 mutants for
their ability to interact with clathrin terminal domains by
measuring the change in peak intensity of 1D proton reso-
nances for each peptide. Because peak heights are in-
versely proportional to the effective molecular weight,
they can be used to calculate the relative binding constant
for each peptide as it interacts with the terminal domain
(see Materials and Methods). Table I shows that the rela-
tive affinity of each peptide for the clathrin terminal do-
main strongly correlated with the predicted turn propen-
sity (2) as well as the ability of receptors bearing these
mutations to internalize LDL (14). Thus, peptides with
Tyr and Phe at position 807 had the highest affinity, the
greatest turn propensity, and the highest internalization
rate, while a Leu at this position had an intermediate affin-
ity and both Ser and Ala had the lowest affinities.
Transferred NOEs have been used previously to deter-
mine the conformation of peptides bound to proteins (26,
27, 49). These results have later been confirmed from crys-
tal structures of the complexes (40, 57, 62). We used data
from transferred NOE spectra to determine the structure
of the FDNPVY motif bound to clathrin cages. Similar
NOE results were obtained when cages were replaced
with recombinant terminal domains (data not shown).
Structures were calculated by simulated annealing (37) us-
ing 30 nontrivial transferred NOE restraints. Among
these, 23 NOEs correspond to the residues NPVY, includ-
ing the strong NH/NH NOE between Val and Tyr charac-
teristic of a turn conformation (Fig. 6 A), and other short
and intermediate range, structurally diagnostic NOEs. A
superposition of the peptide backbones for the 21 struc-
tures with distance violations of ,0.1 Å obtained among
30 calculated structures is shown in Fig. 6 B. All resulting
structures had an extended NH2 terminus followed by a
Type 1 b turn around residues NPVY. The two NH2-ter-
minal amino acids did not align as well in the superposi-
tion. This result is more likely to arise from a lack of pro-
ton density in the extended structure of this region than
Figure 4. Differential broadening of the wild-type and mutant
hexapeptides in the presence of assembled clathrin cages re-
constituted with and without AP-2. Corresponding regions of
1-dimensional  1H NMR from the aromatic region of the spectra
are shown at absolute intensity. The indicated peptide (final con-
centration 1.5 mM) was added to buffer alone or buffer plus 9.7
mg/ml protein: FDNPVY alone (A), plus clathrin cages (B), plus
clathrin and AP-2 cages (C), FDNPVS alone (D), plus clathrin
cages (E), or plus clathrin and AP-2 cages. NMR samples were
prepared as described for Fig. 1. Because of differing concentra-
tions of peptide and protein, the absolute signal intensity can not
be directly compared with those in Fig. 1.
Figure 5. Differential line-broadening of internalization peptides
in the presence and absence of recombinant clathrin terminal do-
mains and hubs. Corresponding regions of 1-dimensional 1H
NMR from the aromatic region of the spectra are shown at abso-
lute intensity. Samples contained 1.0 mM peptide with or without
175 mM clathrin terminal domain TD(1–579) at pH 6.2 as follows:
FDNPVY alone (A), plus TD(1–579) (B) or FDNPVS alone (C),
plus TD(1–579) (D). The interactions of the wild-type hexapep-
tide (1 mM) with 200 mM of either TD(1–579) or clathrin
Hub(1074–1483) were compared at pH 7.2 in 150 mM KCl. Sam-
ples contained: FDNPVY alone (E), plus TD(1–579) (F), or plus
Hub(1074–1483) (G).The Journal of Cell Biology, Volume 142, 1998 64
from increased mobility, since line-broadening and trans-
ferred NOE build-up rates indicate that Phe is immobilized
(see above). The 21 calculated structures had a backbone
root mean square deviation of 0.61 Å, indicating that a sin-
gle conformational form of the peptide was bound by the
cages. Based on this information, a representative structure
is shown in Fig. 6 C.
Discussion
The surprising conclusion of this study is that clathrin may
be the molecule in coated pits responsible for capturing
the LDL receptor during receptor-mediated endocytosis.
Four stringent criteria were used to distinguish specific
from nonspecific interactions between the clustering motif
peptide and clathrin. First, changing tyrosine 807 to serine,
which matches the mutation that prevents LDL receptor
clustering in coated pits (13), substantially reduced inter-
action of the peptide with the cages. Second, the wild-type
peptide bound to the cages in a single conformation, and
had the predicted (2, 12) reverse turn conformation. Third,
Table I. 
Peptide Kd* Internalization index‡ Turn propensity§
mM
FDNPVY 0.14 1.0 1.0
FDNPVF 0.33 0.95 0.75
FDNPVL 0.63 0.30 ND
FDNPVS 1.4 0.20 0
FDNPVA 3.1 0.20 0
*The relative Kd calculated from Phe(3,5) aromatic proton peak intensities as de-
scribed in the experimental procedures. ‡Normalized to the native receptor (14).
§Using NOE magnitudes as an indicator for turn propensity, scaled to that for the
NPVY peptide (2). ND, not determined.
Figure 6. Cage-bound struc-
ture of FDNPVY calculated
from transferred NOE-
derived restraints. (A) Con-
tour plot of the transferred
NOE between Tyr(HN)
(7.71 ppm) and Val(HN)
(8.07 ppm) from the
hexapeptide with a 60-ms
mixing time. (B) The super-
imposed backbones of 21 cal-
culated structures obtained
by simulated annealing. (C)
A single representative struc-
ture of the AcFDNPVY pep-
tide bound to clathrin-AP
cages.Kibbey et al. Clathrin Clusters LDL Receptors 65
binding was limited to those residues that lie within the
FXNPXY motif. Fourth, once clathrin was identified as a
candidate molecule, the wild-type peptide was found to in-
teract with the terminal domain, but not with the hub por-
tion of recombinant clathrin. Furthermore, the relative af-
finity of terminal domains for peptides with various
position 807 substitutions correlated strongly with both
the LDL receptor internalization index (14) and the pre-
dicted turn propensity (2). These results suggest that the
receptor internalization rates depend on the affinities of
the hexapeptide motif for clathrin, and that the affinity de-
pends on a reverse turn conformation.
The apparent affinity we measured between the hexa-
peptides and clathrin terminal domains is in the same
range as that reported for the interaction between YXXF
peptides and the m subunit of AP (4, 44). It is hard to judge
the functional significance of these affinities. Within the
cell, LDL receptors probably exist as multimers interact-
ing with the rigid clathrin lattice in a two-dimensional
plane (52). In this environment, the receptors will have a
restricted rotational and translational mobility as they in-
teract with a multivalent, nearly crystalline set of terminal
domains. Assuming that a 76-nm–diameter clathrin-coated
vesicle contains 60 clathrin triskelions (21), we calculated
the concentration of terminal domains to be at minimum
1.5 mM. This result suggests the effective concentration of
terminal domains in the region where receptor cluster is
quite high, so the relatively low-affinity interactions we
have measured should be sufficient to mediate clustering.
Clathrin terminal domains have been implicated before
in receptor clustering (17, 18). The binding of b-arrestin to
the phosphorylated cytoplasmic tail of the b2-adrenergic
receptor appears to be required for receptor migration to
coated pits. The binding of b-arrestins to clathrin is stoi-
chiometric, clustering in coated pits is coincident with re-
ceptor internalization, and expression of b-arrestin medi-
ates internalization (18). The b-arrestin binding site has
been localized to the first 100 amino acids of the clathrin
heavy chain (17). Structural studies show that the terminal
domain of clathrin is optimally positioned in an assembled
lattice to interact with the cytoplasmic tails of receptors
(53). However, none of these studies have sufficient reso-
lution to determine the location of the terminal domains in
an assembled clathrin coat.
Although clathrin terminal domains clearly interact with
the NPXY clustering motif, we have not ruled out the pos-
sibility that APs can bind to the cytoplasmic portion of the
LDL receptor, or that they can modulate the interaction of
the NXPY motif with clathrin. The presence of AP2 in
our clathrin cage preparations moderately enhanced line-
broadening of the NMR spectra compared with clathrin
alone, suggesting that the wild-type peptides may have a
higher affinity for cages containing AP2 (Fig. 4). The
bound peptide displayed a well-defined conformation in
the presence or absence of APs, so broadening must be
due to a single type of binding site for the hexapeptide.
Therefore, most likely the enhanced broadening is not due
to introduction of additional hexapeptide binding sites
present in the APs.
Our results stand in contrast to previous studies showing
that purified AP2 binds substoichiometrically to a fusion
protein containing the cytoplasmic tail of the LDL recep-
tor (42). The fusion protein used in this study contained 31
residues from the lcII protein, a thrombin cleavage site,
112 residues of myosin light chain, a second thrombin
cleavage site, and the 50-residue LDL receptor tail (42).
Interestingly, the cII fragment contains a dileucine motif
that can directly interact with APs (20, 43). Since a fusion
protein containing an internalization-defective LDL re-
ceptor tail (e.g., Y807C) was not tested, these studies did
not rule out the possibility that the interaction with AP2
was mediated by the dileucine motif. Moreover, there is
compelling in vivo evidence that AP2 does not cluster
LDL receptors. Depletion of intracellular K1 and hyper-
tonic treatment of cells both cause reversible loss of clath-
rin lattices from the cell surface (22, 28), which is accom-
panied by LDL receptor unclustering (22, 28). By contrast,
these conditions do not uncluster AP2 (19). If receptor
clustering were primarily dependent on AP2, then LDL
receptors should have remained clustered under these
conditions.
An important prediction from these results is that LDL
receptors should be sorted and concentrated during clath-
rin-coated vesicle formation regardless of whether bud-
ding occurs from Golgi, endosome, or surface membranes.
Coated vesicles purified from adrenal glands are enriched
in masked LDL receptors four to fivefold (33). These iso-
lated vesicles contain coated vesicle derived from both the
plasma membrane and the Golgi apparatus that can be
separated on the basis of size (5). Ligand blotting indicates
that both populations of vesicles are equally enriched in
LDL receptors relative to the plasma membrane (5).
Therefore, even though there are no quantitative EM
studies showing LDL receptors concentrated in Golgi-
coated vesicles, these biochemical experiments suggest
that sorting does occur.
AP2 does appear to be responsible for capturing recep-
tors that contain YXXF (39) and dileucine internalization
motifs (20, 43). Two-hybrid screen (38, 39) and surface
plasmon resonance analysis (4, 39) both show that YXXF
interacts with the m chain of AP2. The properties of
YXXF motif are distinct from those for FXNPXY since
FXNPXY motifs did not bind the m subunit, and a combi-
natorial library showed no preference for this motif (4).
Dileucine motifs also bind clathrin AP2 and AP1, yet re-
ceptors with this motif do not compete with receptors con-
taining YXXF during internalization (31). Receptor inter-
nalization by coated pits can therefore be mediated by at
least three distinct motifs (two tyrosine-based and one
dileucine-based), each of which is captured by a different
binding site in the lattice.
Tyrosine phosphorylation alters the binding specificity
of both YXXF and NPXY, although phosphorylation is
not essential for binding to all phosphotyrosine binding
(PTB) domains (6, 59). pYXXF binds SH2 domains (46)
while NPXpY binds proteins that contain a PTB domain
(51). The structures of both pYXXF/SH2 (16, 54, 55) and
NPXpY/PTB domain (15, 60, 61) complexes have been
solved. The former shows that pYXXF binds as an ex-
tended two-pronged plug. The structure of the latter con-
firms transferred NOE data (61) showing that the tyrosine
in the bound NPXpY is in a tight turn preceded by an ex-
tended region. Since we found that bound FXNPXY is in a
tight turn (Fig. 6 C), it is possible the simple addition ofThe Journal of Cell Biology, Volume 142, 1998 66
phosphate or specific expression of a PTB domain blocks
coated pit clustering. The conformation of YXXF bound
to the m chain of AP has not been determined, but if the
phosphate is also what changes binding specificity, then
the bound conformation of YXXF should be an extended,
two-pronged plug rather than a tight turn.
This study demonstrates the power of NMR spectros-
copy to identify the molecules in coat protein complexes
responsible for sorting membrane proteins during vesicu-
lar traffic. At the same time, this method provides dy-
namic structural information about the targeting sequence
when it is bound. Multiple targeting motifs regulate recep-
tor trafficking throughout the cell. Internalization motifs
can function at multiple steps along an internalization
pathway, differentially using clathrin and AP subunits to
generate different migratory patterns. The specificity of
clathrin for FXNPXY and APs for YXXF appears to be as
distinct as PTB and SH2 domains are for their phosphory-
lated counterparts. YXXF and dileucine motifs may target
receptors to plasma membrane, late endosome, lysosome,
and TGN structures via combinatorial interactions with
AP complexes and possibly other membrane coats. By
contrast, the FXNPXY motif may be needed for efficient
clathrin-mediated recycling of LDL receptors between the
plasma membrane and endosomes. Based only on the pri-
mary sequence of these motifs, it has not been possible to
predict the cellular distribution of receptors. NMR spec-
troscopy should be useful to characterize further the con-
formational determinants of sorting motifs that ultimately
determine receptor sorting patterns.
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